LatinoWire

December 13, 2024 07:51 AM Eastern Time

BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell

Opens in new window

Download

Full Size JPEG, 1476x542, 211.5 KB
Small JPEG, 480x176, 39.3 KB
Preview JPEG, 144x53, 6.5 KB
Thumbnail JPEG, 120x44, 4.7 KB

Smart Multimedia Gallery

http://www.businesswire.com/multimedia/latinowire/20241213410573/en/5761494/BrightPath-Bio-and-Cellistic-Announces-Process-Development-and-Manufacturing-Collaboration-for-Phase-1-Clinical-Trial-of-iPSC-derived-BCMA-CAR-iNKT-cell

Share

Email

All News | News with Multimedia > Press Release: BrightPath Bio and Cellistic Announces Process ...

Get Business Wire News on Your Website

Terms of Use | © 2024 Business Wire